NCT01680185View on ClinicalTrials.gov

Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Hyperglycemia
Interventions
DRUG

Insulin lispro, Humalog (Eli Lilly) in insulin pump

all covered above

DRUG

Human insulin isophane, Humulin N (Eli Lilly)

all covered above

OTHER

Standard of care

all covered above

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01680185 - Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation | Biotech Hunter | Biotech Hunter